: Moderna confirms COVID sales guidance as shares sink on Pfizer news

Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain

Previous post Market Extra: UBS says Treasurys are poised for a powerful rebound as outlook for U.S. stocks dims
Next post In rare move, Ford chairman calls on UAW to make a deal and end ‘acrimonious’ talks